469 related articles for article (PubMed ID: 14612286)
1. Early prediction of severe acute pancreatitis by urinary trypsinogen activation peptide.
Liu ZS; Jiang CQ; Qian Q; Sun Q; Fan LF; Ai ZL
Hepatobiliary Pancreat Dis Int; 2002 May; 1(2):285-9. PubMed ID: 14612286
[TBL] [Abstract][Full Text] [Related]
2. Urinary trypsinogen activation peptide as a marker of severe acute pancreatitis.
Johnson CD; Lempinen M; Imrie CW; Puolakkainen P; Kemppainen E; Carter R; McKay C
Br J Surg; 2004 Aug; 91(8):1027-33. PubMed ID: 15286966
[TBL] [Abstract][Full Text] [Related]
3. Urinary trypsinogen activation peptide is more accurate than hematocrit in determining severity in patients with acute pancreatitis: a prospective study.
Khan Z; Vlodov J; Horovitz J; Jose RM; Iswara K; Smotkin J; Brown A; Tenner S
Am J Gastroenterol; 2002 Aug; 97(8):1973-7. PubMed ID: 12190163
[TBL] [Abstract][Full Text] [Related]
4. Calcitonin precursors in the prediction of severity of acute pancreatitis on the day of admission.
Ammori BJ; Becker KL; Kite P; Snider RH; Nylén ES; White JC; Larvin M; McMahon MJ
Br J Surg; 2003 Feb; 90(2):197-204. PubMed ID: 12555296
[TBL] [Abstract][Full Text] [Related]
5. Early prediction of severity in acute pancreatitis by urinary trypsinogen activation peptide: a multicentre study.
Neoptolemos JP; Kemppainen EA; Mayer JM; Fitzpatrick JM; Raraty MG; Slavin J; Beger HG; Hietaranta AJ; Puolakkainen PA
Lancet; 2000 Jun; 355(9219):1955-60. PubMed ID: 10859041
[TBL] [Abstract][Full Text] [Related]
6. Early prediction of severity in acute pancreatitis using infrared spectroscopy of serum.
Petrov MS; Gordetzov AS; Kukosh MV
Pancreatology; 2007; 7(5-6):451-8. PubMed ID: 17912016
[TBL] [Abstract][Full Text] [Related]
7. APACHE system is better than Ranson system in the prediction of severity of acute pancreatitis.
Yeung YP; Lam BY; Yip AW
Hepatobiliary Pancreat Dis Int; 2006 May; 5(2):294-9. PubMed ID: 16698595
[TBL] [Abstract][Full Text] [Related]
8. Proinflammatory cytokines in early assessment of the prognosis of acute pancreatitis.
Chen CC; Wang SS; Lee FY; Chang FY; Lee SD
Am J Gastroenterol; 1999 Jan; 94(1):213-8. PubMed ID: 9934758
[TBL] [Abstract][Full Text] [Related]
9. Trypsinogen-2 and trypsinogen activation peptide (TAP) in urine of patients with acute pancreatitis.
Lempinen M; Stenman UH; Finne P; Puolakkainen P; Haapiainen R; Kemppainen E
J Surg Res; 2003 May; 111(2):267-73. PubMed ID: 12850473
[TBL] [Abstract][Full Text] [Related]
10. Serum amyloid A is a better early predictor of severity than C-reactive protein in acute pancreatitis.
Mayer JM; Raraty M; Slavin J; Kemppainen E; Fitzpatrick J; Hietaranta A; Puolakkainen P; Beger HG; Neoptolemos JP
Br J Surg; 2002 Feb; 89(2):163-71. PubMed ID: 11856128
[TBL] [Abstract][Full Text] [Related]
11. A comparative study of the urinary trypsinogen-2, trypsinogen activation peptide, and the computed tomography severity index as early predictors of the severity of acute pancreatitis.
Huang QL; Qian ZX; Li H
Hepatogastroenterology; 2010; 57(102-103):1295-9. PubMed ID: 21410075
[TBL] [Abstract][Full Text] [Related]
12. Combination of APACHE-II score and an obesity score (APACHE-O) for the prediction of severe acute pancreatitis.
Johnson CD; Toh SK; Campbell MJ
Pancreatology; 2004; 4(1):1-6. PubMed ID: 14988652
[TBL] [Abstract][Full Text] [Related]
13. Comparison and validation of scoring systems in a cohort of patients treated for biliary acute pancreatitis.
Göçmen E; Klc YA; Yoldaş O; Ertan T; Karaköse N; Koç M; Tez M
Pancreas; 2007 Jan; 34(1):66-9. PubMed ID: 17198185
[TBL] [Abstract][Full Text] [Related]
14. A comparison of serum trypsinogen-2 and trypsin-2-alpha1-antitrypsin complex with lipase and amylase in the diagnosis and assessment of severity in the early phase of acute pancreatitis.
Hedström J; Kemppainen E; Andersén J; Jokela H; Puolakkainen P; Stenman UH
Am J Gastroenterol; 2001 Feb; 96(2):424-30. PubMed ID: 11232685
[TBL] [Abstract][Full Text] [Related]
15. [Prediction and monitoring of severe acute pancreatitis].
Gürlich R; Maruna P; Spicák J
Cas Lek Cesk; 2006; 145(6):437-41; discussion 442. PubMed ID: 16835994
[TBL] [Abstract][Full Text] [Related]
16. Urinary trypsinogen activation peptide (TAP) predicts severity in patients with acute pancreatitis.
Tenner S; Fernandez-del Castillo C; Warshaw A; Steinberg W; Hermon-Taylor J; Valenzuela JE; Hariri M; Hughes M; Banks PA
Int J Pancreatol; 1997 Apr; 21(2):105-10. PubMed ID: 9209951
[TBL] [Abstract][Full Text] [Related]
17. Predictors of severity and survival in acute pancreatitis: validation of the efficacy of early warning scores.
Garcea G; Gouda M; Hebbes C; Ong SL; Neal CP; Dennison AR; Berry DP
Pancreas; 2008 Oct; 37(3):e54-61. PubMed ID: 18815539
[TBL] [Abstract][Full Text] [Related]
18. Early prediction of severity in acute pancreatitis. Is this possible?
Sandberg AA; Borgström A
JOP; 2002 Sep; 3(5):116-25. PubMed ID: 12221326
[TBL] [Abstract][Full Text] [Related]
19. Clinical evaluation of serum interleukin 10 in patients with acute pancreatitis.
Han XC; Zhang YC; Wang Y; Jia MK
Hepatobiliary Pancreat Dis Int; 2003 Feb; 2(1):135-8. PubMed ID: 14607666
[TBL] [Abstract][Full Text] [Related]
20. Serum and urine concentrations of trypsinogen-activation peptide as markers for acute pancreatitis in cats.
Allen HS; Steiner J; Broussard J; Mansfield C; Williams DA; Jones B
Can J Vet Res; 2006 Oct; 70(4):313-6. PubMed ID: 17042387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
